glp-1 metformin Treatment Algorithm: Where GLP-1 Drugs Fit Are GLP-1s and SGLT2s replacements
Description
2024 Study Warns About GLP-1 Gastric Side Effects In the latest study, a group of researchers from Beijing University of Chinese Medicine and the University of Chicago performed a systemic review of 76 studies to evaluate the comparative safety and effectiveness of fifteen different GLP-1 receptor agonists, including semaglutide (Ozempic and Wegovy), tirzepatide (Mounjaro and Zepbound), exenatide (Byetta and Bydureon) and other commonly prescribed brands
The longer answer requires understanding several interconnected safety concerns
R.VaduganathanM
The first GLP-1 receptor agonist approved by the FDA was exenatide in 2005, derived directly from the lizard venom compound
To help patients stay safe if they are using Zepbound, Wegovy, Ozempic and Mounjaro, we consulted with experts
